A Common Variant Upstream of the PAX6 Gene Influences Islet Function in Man

Overview

Journal Diabetologia

Specialty Endocrinology

Date 2011 Sep 17

PMID 21922321

Citations 18

Authors

E Ahlqvist

F Turrini

S T Lang

J Taneera

Y Zhou

P Almgren

O Hansson

B Isomaa

T Tuomi

K Eriksson

J G Eriksson

V Lyssenko

L Groop

Affiliations

Soon will be listed here.

Abstract

Aims/hypothesis: Impaired glucose tolerance and impaired insulin secretion have been reported in families with PAX6 mutations and it is suggested that they result from defective proinsulin processing due to lack of prohormone convertase 1/3, encoded by PCSK1. We investigated whether a common PAX6 variant would mimic these findings and explored in detail its effect on islet function in man.

Methods: A PAX6 candidate single nucleotide polymorphism (rs685428) was associated with fasting insulin levels in the Diabetes Genetics Initiative genome-wide association study. We explored its potential association with glucose tolerance and insulin processing and secretion in three Scandinavian cohorts (N = 8,897 individuals). In addition, insulin secretion and the expression of PAX6 and transcriptional target genes were studied in human pancreatic islets.

Results: rs685428 G allele carriers had lower islet mRNA expression of PAX6 (p = 0.01) and PCSK1 (p = 0.001) than AA homozygotes. The G allele was associated with increased fasting insulin (p (replication) = 0.02, p (all) = 0.0008) and HOMA-insulin resistance (p (replication) = 0.02, p (all) = 0.001) as well as a lower fasting proinsulin/insulin ratio (p (all) = 0.008) and lower fasting glucagon (p = 0.04) and gastric inhibitory peptide (GIP) (p = 0.05) concentrations. Arginine-stimulated (p = 0.02) insulin secretion was reduced in vivo, which was further reflected by a reduction of glucose- and potassium-stimulated insulin secretion (p = 0.002 and p = 0.04, respectively) in human islets in vitro.

Conclusions/interpretation: A common variant in PAX6 is associated with reduced PAX6 and PCSK1 expression in human islets and reduced insulin response, as well as decreased glucagon and GIP concentrations and decreased insulin sensitivity. These findings emphasise the central role of PAX6 in the regulation of islet function and glucose metabolism in man.

Citing Articles

scParser: sparse representation learning for scalable single-cell RNA sequencing data analysis.

Zhao K, So H, Lin Z Genome Biol. 2024; 25(1):223.

PMID: 39152499 PMC: 11328435. DOI: 10.1186/s13059-024-03345-0.

Transcriptional Signatures and Network-Based Approaches Identified Master Regulators Transcription Factors Involved in Experimental Periodontitis Pathogenesis.

Vicencio E, Nunez-Belmar J, Cardenas J, Cortes B, Martin A, Maracaja-Coutinho V Int J Mol Sci. 2023; 24(19).

PMID: 37834287 PMC: 10573220. DOI: 10.3390/ijms241914835.

A critical review on therapeutic approaches of CRISPR-Cas9 in diabetes mellitus.

Bora J, Dey A, Lyngdoh A, Dhasmana A, Ranjan A, Kishore S Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(12):3459-3481.

PMID: 37522916 DOI: 10.1007/s00210-023-02631-1.

Transient Hyperinsulinemic Hypoglycemia Linked to Mutation.

Kim J, Kim S, Kim S, Cho W, Cho K, Jung M Medicina (Kaunas). 2021; 57(6).

PMID: 34200146 PMC: 8227506. DOI: 10.3390/medicina57060582.

Lack of association between PAX6/SOSTDC1/FAM20B gene polymorphisms and mesiodens.

Liu S, Li J, Xu J, Liao S, Chen Y, Zhang R BMC Oral Health. 2019; 19(1):90.

PMID: 31133012 PMC: 6537368. DOI: 10.1186/s12903-019-0788-3.

References

Goke B . Islet cell function: alpha and beta cells--partners towards normoglycaemia. Int J Clin Pract Suppl. 2008; (159):2-7. DOI: 10.1111/j.1742-1241.2007.01686.x. View

Roder M, Porte Jr D, Schwartz R, Kahn S . Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1998; 83(2):604-8. DOI: 10.1210/jcem.83.2.4544. View

Wen J, Chen Y, Song S, Ding J, Gao Y, Hu Q . Paired box 6 (PAX6) regulates glucose metabolism via proinsulin processing mediated by prohormone convertase 1/3 (PC1/3). Diabetologia. 2008; 52(3):504-13. DOI: 10.1007/s00125-008-1210-x. View

Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson A . New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010; 42(2):105-16. PMC: 3018764. DOI: 10.1038/ng.520. View

Guillam M, Hummler E, SCHAERER E, Yeh J, Birnbaum M, Beermann F . Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2. Nat Genet. 1997; 17(3):327-30. DOI: 10.1038/ng1197-327. View

Nogales-Cadenas R, Carmona-Saez P, Vazquez M, Vicente C, Yang X, Tirado F . GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information. Nucleic Acids Res. 2009; 37(Web Server issue):W317-22. PMC: 2703901. DOI: 10.1093/nar/gkp416. View

Voight B, Scott L, Steinthorsdottir V, Morris A, Dina C, Welch R . Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010; 42(7):579-89. PMC: 3080658. DOI: 10.1038/ng.609. View

Sandhu M, Weedon M, Fawcett K, Wasson J, Debenham S, Daly A . Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet. 2007; 39(8):951-3. PMC: 2672152. DOI: 10.1038/ng2067. View

Ugleholdt R, Zhu X, Deacon C, Orskov C, Steiner D, Holst J . Impaired intestinal proglucagon processing in mice lacking prohormone convertase 1. Endocrinology. 2003; 145(3):1349-55. DOI: 10.1210/en.2003-0801. View

10.

Katz L, Gosmain Y, Marthinet E, Philippe J . Pax6 regulates the proglucagon processing enzyme PC2 and its chaperone 7B2. Mol Cell Biol. 2009; 29(8):2322-34. PMC: 2663301. DOI: 10.1128/MCB.01543-08. View

11.

Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A . Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002; 3(7):RESEARCH0034. PMC: 126239. DOI: 10.1186/gb-2002-3-7-research0034. View

12.

Kaneto H, Matsuoka T, Miyatsuka T, Kawamori D, Katakami N, Yamasaki Y . PDX-1 functions as a master factor in the pancreas. Front Biosci. 2008; 13:6406-20. DOI: 10.2741/3162. View

13.

Hanley A, DAgostino Jr R, Wagenknecht L, Saad M, Savage P, Bergman R . Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study. Diabetes. 2002; 51(4):1263-70. DOI: 10.2337/diabetes.51.4.1263. View

14.

Unger R, Orci L . The essential role of glucagon in the pathogenesis of diabetes mellitus. Lancet. 1975; 1(7897):14-6. DOI: 10.1016/s0140-6736(75)92375-2. View

15.

Ugleholdt R, Poulsen M, Holst P, Irminger J, Orskov C, Pedersen J . Prohormone convertase 1/3 is essential for processing of the glucose-dependent insulinotropic polypeptide precursor. J Biol Chem. 2006; 281(16):11050-7. DOI: 10.1074/jbc.M601203200. View

16.

Nishi M, Sasahara M, Shono T, Saika S, Yamamoto Y, Ohkawa K . A case of novel de novo paired box gene 6 (PAX6) mutation with early-onset diabetes mellitus and aniridia. Diabet Med. 2005; 22(5):641-4. DOI: 10.1111/j.1464-5491.2005.01469.x. View

17.

Eriksson J, Osmond C, Kajantie E, Forsen T, Barker D . Patterns of growth among children who later develop type 2 diabetes or its risk factors. Diabetologia. 2006; 49(12):2853-8. DOI: 10.1007/s00125-006-0459-1. View

18.

Yasuda T, Kajimoto Y, Fujitani Y, Watada H, Yamamoto S, Watarai T . PAX6 mutation as a genetic factor common to aniridia and glucose intolerance. Diabetes. 2002; 51(1):224-30. DOI: 10.2337/diabetes.51.1.224. View

19.

Ritz-Laser B, Estreicher A, Gauthier B, Mamin A, Edlund H, Philippe J . The pancreatic beta-cell-specific transcription factor Pax-4 inhibits glucagon gene expression through Pax-6. Diabetologia. 2002; 45(1):97-107. DOI: 10.1007/s125-002-8249-9. View

20.

Ashery-Padan R, Zhou X, Marquardt T, Herrera P, Toube L, Berry A . Conditional inactivation of Pax6 in the pancreas causes early onset of diabetes. Dev Biol. 2004; 269(2):479-88. DOI: 10.1016/j.ydbio.2004.01.040. View